Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Max van Noesel

Co-Principal Investigator
Dr. Max van Noesel is pediatric oncologist and scientist. Together with prof. dr. Jan Molenaar he focuses on the development of better treatment options for children with neuroblastoma.
  • Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy

    • feb. 2024
    • Judith, Wienke, et al
    • Cancer Cell
  • Two opposing gene expression patterns within ATRX aberrant neuroblastoma

    • aug. 2023
    • Michael R, van Gerven, et al
    • PloS one
  • Biologicals as theranostic vehicles in paediatric oncology

    • nov. 2022
    • Veerle J.A., Niessen, et al
    • Nuclear Medicine and Biology
  • Implementation of paediatric precision oncology into clinical practice

    • nov. 2022
    • Karin P.S., Langenberg, et al
    • European Journal of Cancer
  • Pleuropulmonary blastoma (PPB) and other DICER1-associated high-grade malignancies are morphologically, genetically and epigenetically related - A comparative study of 4 PPBs and 6 sarcomas

    • okt. 2022
    • L S, Hiemcke-Jiwa, et al
    • Annals of diagnostic pathology
View all publications